Skip to search formSkip to main contentSkip to account menu

PTT 119

Known as: PTT-119, PTT.119 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe cancericidal efficacy of a new synthetic tripeptide was demonstrated using both in vitro cultures and in vivo… 
2004
2004
SummaryIn a phase II study we evaluated the effect and toxicity of a new alkylating agent, PTT-119, in 26 patients with non… 
1990
1990
SummaryPTT-119 is an antineoplastic agent in which an alkylating moiety, m-sarcolysine, is linked to two amino acid analogs… 
1990
1990
SummaryIn a phase II cooperative study involving eleven Italian haematological units, the efficacy and toxicity of a new… 
1988
1988
Uptake of the bifunctional alkylating agent, PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy-HCl, by the MJY-alpha… 
1988
1988
The pharmacokinetics of PTT-119, a new alkylating agent, was studied in 8 advanced cancer patients. PTT-119 disappeared rapidly… 
1987
1987
The new synthetic tripeptide p-F-Phe-m-bis-(2-chloro-ethyl)amino-Phe-Met-etoxy HCl, PTT.119, was studied for its effects on the… 
1985
1985
The new synthetic tripeptide, p-fluoro-L-phenylalanyl-m-bis-(2-chloroethyl)- amino-L-phenylalanyl-methionine ethylester… 
1984
1984
SummaryA new synthetic tripeptide (p-F-Phe-m-bis-(2-chloroethyl)amino-Phe-Met ethoxy HCl), PTT.119, was demonstrated to have… 
1983
1983
  • M. YagiJ. Bekesi
  • 1983
  • Corpus ID: 33698960
PTT.119 is a new synthetic compound under assessment as a chemotherapeutic agent against neoplasia. Exposure of three diverse…